Filters

Tranexamic acid manufacturers

Filters

Filters

Filters , active

Country of origin : Pakistan
None products found

tranexamic acid

Capsules 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750
This pharmaceutical company boasts a vast portfolio of over 500 products spanning numerous therapeutic areas, including those focusing on prescription medications and over-the-counter drugs. They emphasize stringent quality control measures, adhering to GMP certifications and international regulatory standards. Their research and development department actively works on new drug candidates and improving existing formulations. The company has a global presence with operations in regions like the EU and North America. They offer a range of dosage forms and hold multiple patents for their innovative products.

Manufacturer usually replies in 2 days

tranexamic acid

Injection 250 mg/5 ml, 500 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #19907

This company is a global pharmaceutical manufacturer with a focus on providing high-quality, affordable branded generic formulations. They have a strong track record spanning over 25 years, evident in their flagship brand's longevity. Their production lines encompass prescription medications, over-the-counter drugs, and supplements, catering to diverse therapeutic areas such as cardiology, gastroenterology, and central nervous system disorders. The company prioritizes quality control and assurance, adhering to strict GMP certifications. They have a presence in over 50 countries across regions like North America and the EU. Their commitment to innovation is demonstrated by their continuous investments in research and development, leading to several product patents.

Manufacturer usually replies in 45 days

tranexamic acid

Capsules 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #19907

This company is a global pharmaceutical manufacturer with a focus on providing high-quality, affordable branded generic formulations. They have a strong track record spanning over 25 years, evident in their flagship brand's longevity. Their production lines encompass prescription medications, over-the-counter drugs, and supplements, catering to diverse therapeutic areas such as cardiology, gastroenterology, and central nervous system disorders. The company prioritizes quality control and assurance, adhering to strict GMP certifications. They have a presence in over 50 countries across regions like North America and the EU. Their commitment to innovation is demonstrated by their continuous investments in research and development, leading to several product patents.

Manufacturer usually replies in 45 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid. Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets. In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis. Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.